Circulating Cell-Free DNA as Inflammatory Marker in Egyptian Psoriasis Patients

References

• Frank MO. Circulating cell-free DNA differentiates severity of inflammation. Biol Res Nurs. 2016;18:477–488. doi:10.1177/109980041664257127067611
   PubMed Web of Science ®Google Scholar
• Penttilä AK, Rouhiainen A, Kylänpää L, et al. Circulating nucleosomes as predictive markers of severe acute pancreatitis. J Intensive Care. 2016;4:14. doi:10.1186/s40560-016-0135-626893906
   PubMed Web of Science ®Google Scholar
• Chen Q, Ye L, Jin Y, et al. Circulating nucleosomes as a predictor of sepsis and organ dysfunction in critically ill patients. Int J Infect Dis. 2012;16:e558–e564. doi:10.1016/j.ijid.2012.03.00722609014
   PubMed Web of Science ®Google Scholar
• Tovbin D, Novack V, Wiessman MP, et al. Circulating cell-free DNA in hemodialysis patients predicts mortality. Nephrol Dial Transplant. 2012;27:3929–3935. doi:10.1093/ndt/gfs25522833622
   PubMed Web of Science ®Google Scholar
• He L, Qin S, Dang L, et al. Psoriasis decreases the antioxidation and anti-inflammation properties of high-density lipoprotein. Biochim Biophys Acta. 2014;1841:1709–1715. doi:10.1016/j.bbalip.2014.09.00825240836
   PubMed Web of Science ®Google Scholar
• Kohlova M, Ribeiro S, Do Sameiro-Faria M, et al. Circulating cell-free DNA levels in hemodialysis patients and its association with inflammation, iron metabolism, and rhEPO doses. Hemodial Int. 2013;17:664–667. doi:10.1111/hdi.1205523679088
   PubMed Web of Science ®Google Scholar
• Beranek M, Fiala Z, Kremlacek J, et al. Changes in circulating cell‑free DNA and nucleosomes in patients with exacerbated psoriasis. Arch Dermatol Res. 2017;309:815–821. doi:10.1007/s00403-017-1785-529027583
   PubMed Web of Science ®Google Scholar
• Sereflican B, Goksugur N, Bugdayci G, Polat M, Haydar Parlak A. Serum visfatin, adiponectin, and tumor necrosis factor alpha (TNF-α) levels in patients with psoriasis and their correlation with disease severity. Acta Dermatovenerol Croat. 2016;24:13–19.27149125
   PubMed Web of Science ®Google Scholar
• Dilek AR, Dilek N, Saral Y, Yüksel D. The relationship between severity of the disease and circulating nucleosomes in psoriasis patients. Arch Dermatol Res. 2013;305:483–487. doi:10.1007/s00403-013-1347-423567920
   PubMed Web of Science ®Google Scholar
• Zaher H, Shaker OG, EL‐Komy MH, El‐Tawdi A, Fawzi M, Kadry D. Serum and tissue expression of transforming growth factor in psoriasis. J Eur Acad Dermatol Venereol. 2009;23(4):406–409. doi:10.1111/j.1468-3083.2008.03064.x19175705
   PubMed Web of Science ®Google Scholar
• Meki AR, Al-Shobaili H. Serum vascular endothelial growth factor, transforming growth factor β1, and nitric oxide levels in patients with psoriasis vulgaris: their correlation to disease severity. J Clin Lab Anal. 2014;28(6):496–501. doi:10.1002/jcla.2171724659464
   PubMed Web of Science ®Google Scholar
• El-hadidi HH, Hassan AS, El-hanafy G, Amr KS, Abdelmesih SF, Abdelhamid MF. Transforming growth factor-β1 gene polymorphism in psoriasis vulgaris. Clin Cosmet Investig Dermatol. 2018;11:415–419. doi:10.2147/CCID.S171403
   Web of Science ®Google Scholar
• Rasheed H, El-Moaty HA, El-Komy MH, et al. Kasr Al-Ainy’s psoriasis unit protocol for the management of psoriasis, part I: topical and systemic therapies. J Egypt Women’s Dermatologic Soc. 2019;16:1–13. doi:10.4103/JEWD.JEWD_8_19
   Google Scholar
• Rasheed H, El-Moaty HA, El-Komy MH, et al. Kasr AL-Ainy’s psoriasis unit protocol for the treatment of psoriasis, part II: biological therapies. J Egypt Women’s Dermatologic Soc. 2019;16:73–80. doi:10.4103/JEWD.JEWD_13_19
   Google Scholar
• Coimbra S, Catarino C, Costa E, et al. Circulating cell free DNA levels in Portuguese patients with psoriasis vulgaris according to severity and therapy. Br J Dermatol. 2014;170:939–942. doi:10.1111/bjd.1273824245854
   PubMed Web of Science ®Google Scholar
• Jung M, Klotzek S, Lewandowski M, et al. Changes in concentration of DNA in serum and plasma during storage of blood samples. Clin Chem. 2003;49(6):1028–1029. doi:10.1373/49.6.102812766024
   PubMed Web of Science ®Google Scholar
• Goldshtein H, Hausmann MJ, Douvdevani A. A rapid direct fluorescent assay for cell-free DNA quantification in biological fluids. Ann Clin Biochem. 2009;46(Pt 6):488–494. doi:10.1258/acb.2009.00900219729503
   PubMed Web of Science ®Google Scholar
• de Oliveira MFSP, de Oliveira Rocha B, Duarte GV. Psoriasis: classical and emerging comorbidities. An Bras Dermatol. 2015;90:9–20. doi:10.1590/abd1806-4841.2015303825672294
   PubMed Web of Science ®Google Scholar
• Jylhävä J, Lehtimäki T, Jula A, et al. Circulating cell-free DNA is associated with cardiometabolic risk factors: the health 2000 survey. Atherosclerosis. 2014;233:268–271. doi:10.1016/j.atherosclerosis.2013.12.02224529155
   PubMed Web of Science ®Google Scholar
• Coimbra S, Oliveira H, Reis F, et al. Circulating adipokine levels in Portuguese patients with psoriasis vulgaris according to body mass index, severity and therapy. J Eur Acad Dermatol Venereol. 2010;24:1386–1394. doi:10.1111/j.1468-3083.2010.03647.x20337818
   PubMed Web of Science ®Google Scholar
• Muramatsu S, Kubo R, Nishida E, Morita A. Serum interleukin-6 levels in response to biologic treatment in patients with psoriasis. Mod Rheumatol. 2017;27:137–141. doi:10.3109/14397595.2016.117432827194220
   PubMed Web of Science ®Google Scholar
• Nishimoto S, Fukuda D, Higashikuni Y, et al. Obesity induced DNA released from adipocytes stimulates chronic adipose tissue inflammation and insulin resistance. Sci Adv. 2016;2:e1501332. doi:10.1126/sciadv.150133227051864
   PubMed Web of Science ®Google Scholar
• Bevelacqua V, Libra M, Mazzarino MC, et al. Long pentraxin 3: a marker of inflammation in untreated psoriatic patients. Int J Mol Med. 2006;18:415–423.16865225
   PubMed Web of Science ®Google Scholar
• Atamaniuk J, Kopecky C, Skoupy S, et al. Apoptotic cell-free DNA promotes inflammation in haemodialysis patients. Nephrol Dial Transplant. 2012;27:902–905. doi:10.1093/ndt/gfr69522167588
   PubMed Web of Science ®Google Scholar